CVS Group plc (LON:CVSG – Get Free Report) insider Joanne Shaw bought 1,592 shares of CVS Group stock in a transaction dated Monday, August 10th. The stock was acquired at an average cost of GBX 1,287 per share, for a total transaction of £20,489.04.
CVS Group Stock Up 0.4%
Shares of LON:CVSG opened at GBX 1,299 on Friday. The company has a debt-to-equity ratio of 92.34, a current ratio of 1.07 and a quick ratio of 0.90. The stock has a market cap of £889.07 million, a price-to-earnings ratio of 18.85, a P/E/G ratio of 1.77 and a beta of 1.07. The company has a 50 day moving average of GBX 1,238.55 and a 200-day moving average of GBX 1,240.34. CVS Group plc has a one year low of GBX 1,062 and a one year high of GBX 1,648.
CVS Group declared that its Board of Directors has initiated a share repurchase plan on Tuesday, May 26th that allows the company to repurchase 0 outstanding shares. This repurchase authorization allows the company to purchase shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company’s board believes its shares are undervalued.
Wall Street Analyst Weigh In
Read Our Latest Stock Analysis on CVSG
CVS Group Company Profile
CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.
The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.
Recommended Stories
- Five stocks we like better than CVS Group
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.
